Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Caiyan Zhao, MD
Third hospital of Hebei Medical University
Principal Investigator - Daokun Yang, MM
First Affiliated Hospital of Xinjiang Medical University
Principal Investigator - Desheng Xie, MM
Fudan University
Principal Investigator - Enqiang Chen, MD
West China Hospital
Principal Investigator - Fengmei Wang, MD
Tianjin Third Central Hospital
Principal Investigator - Guicheng Wu, MD
Chongqing University Affiliated Three Gorges Hospital
Principal Investigator - Huazhong Chen, MM
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Principal Investigator - Jia Shang
Henan Provincial People's Hospital
Principal Investigator - Jidong Jia, MD
Beijing Friendship Hospital
Principal Investigator - Jie Li, MD
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Principal Investigator - Jinlin Hou, M.M
Nanfang Hospital, Southern Medical University
Principal Investigator - Jun Li, MD
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University)
Principal InvestigatorKOL profile → - Junqi Niu, MD
The First Hospital of Jilin University
Principal Investigator - Liang Chen, MM
Shanghai Public Health Clinical Center
Principal Investigator - Lihua Sun, MD
First Affiliated Hospital of Xinjiang Medical University
Principal Investigator - Lihua Zhong, MM
The Fourth Affiliated Hospital of Harbin Medical University
Principal Investigator - Lvfeng Yao
Mengchao Hepatopiliary Hospital of Fujian Medical University
Principal Investigator - Min Xie
Guangzhou Eighth People's Hospital
Principal Investigator - Min Zhang, MD
Central South University
Principal Investigator - MingQin Lu, MM
The First Hospital of Wenzhou Medical University
Principal Investigator - Minghua Su, MM
First Affiliated Hospital of Guangxi Medical University
Principal Investigator - Peng Hu, MD
The second affiliated hospital of chongqiong medical university
Principal Investigator - Qin Zhang, MD
Shanghai Tong Ren Hospital
Principal Investigator - Qing Xie, MD
Ruijin Hospital
Principal Investigator - Shufang Yuan, MD
LiuZhou People's Hospital
Principal Investigator - Wenhong Zhang, MD
Huashan Hospital
Principal Investigator - Xiaoqing Fu, MM
Hangzhou Xixi hospital
Principal Investigator - Xiaorong Mao, MD
LanZhou University
Principal Investigator - Xingxiang Yang, MM
Sichuan Academy of Medical Sciences
Principal Investigator - Xuebing Yan, MD
The Affiliated Hospital of Xuzhou Medical University
Principal Investigator - Yan Huang, MD
Xiangya Hospital of Central South University
Principal Investigator - Yao Xie, MD
Beijing Ditan Hospital
Principal Investigator - Yawen Luo, MM
Zunyi Medical College
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Mar 2022
- Primary completion
- 30 Jun 2024
- Completion
- 30 Sept 2029
- Last update posted
- 19 Dec 2024
- Registered enrollment
- 640
- Registry id
- NCT06743438
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.